Eurasport
Loos, Nord, 59120, France
Location status: Recruiting
NCT Number: NCT06803446
Interventional research with minimal risks and constraints on the effects of circadian rhythm on glycemic regulation during intense moderate, continuous and intermittent exercise in adolescents living with type 1 diabetes
Interested in participating?
Request Info10 year–16 year
All sexes
Interventional
Not applicable
Loos, Nord, 59120, France
Location status: Recruiting
Single-center, randomized, controlled study in adolescents living with type 1 diabetes. This study aims to evaluate the effect of exercise timing (morning vs. afternoon) and exercise type (continuous vs. intermittent) on blood glucose levels during and after exercise, as well as to assess the effect of exercise timing (morning vs. afternoon) and type of exercise (continuous vs. intermittent) on blood glucose during and after exercise
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
continuous and intermittent exercise on cycloergometer
Time frame: 1 year 10 months september 2026
Observation of time in target, time in hypoglycemia and time in hyperglycemia
Lille University
Other
Effets du Rythme Circadien Sur la régulation glycémique Lors d'Exercices modérés Continus et Intermittents Intenses Chez Des Adolescents Vivant Avec le diabète de Type 1
Acronym: CHRONODIAB1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07413874
Addison Disease, Adrenal Gland Diseases
Boone, North Carolina, United States
View Trial DetailsNCT06524960
Autoimmune Diseases, Diabetes Mellitus
Birmingham, Alabama, United States
View Trial DetailsNCT06654713
Autoimmune Diseases, Diabetes Mellitus
San Francisco, California, United States
View Trial DetailsNCT06783309
Autoimmune Diseases, Diabetes Mellitus
Tucson, Arizona, United States
View Trial Details